Iżrael - Ingliż - Ministry of Health

sam-on ltd - folic acid; iron as hydroxide polymaltose complex - tablets - folic acid 0.4 mg; iron as hydroxide polymaltose complex 100 mg - ferrous amino acid complex - prevention and treatment of anemia caused by iron and folic acid deficiency including anemia of pregnancy and lactation

Għarabja Sawdita - Ingliż - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sam american, united states - tablet - 12.3.31 mg - royal jelly, bee pollen, boron, minerals, vitamens

Filippini - Ingliż - FDA (Food And Drug Administration)

ferrous fumarate (eq. to 165 mg elemental iron): riboflavin (vit. b2); cyanocobalamin (vit. b12); folic acid - capsule - 500 mg/ 2mg / 3mcg/ 230 mcg

Bangladexx - Ingliż - DGDA (Directorate General of Drug Administration)

mystic pharmaceuticals ltd. - ferrous sulphate + folic acid + zinc - capsule - 150 mg + 500 mcg + 22.5 mg

Emirati Għarab Maqgħuda - Ingliż - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

al ittihad drug store italy - 24's [24x2g sachets] - granules - combination - nutrition , blood-vitamins

Filippini - Ingliż - FDA (Food And Drug Administration)

eadriex pharmaceuticals phils., inc.; importer: n/a; distributor: westfield pharmaceuticals, inc - multivitamins , iron , folic acid - capsule - ferrous sulfate (equivalent to 60 mg elemental iron) 200 mg, thiamine mononitrate (vitamin b1) 10 mg, riboflavin (vitamin b2) 5 mg, pyridoxine hcl (vitamin b6) 5 mg, cyanocobalamin (vitamin b12) 20 mcg, folic acid 400 mcg

Emirati Għarab Maqgħuda - Ingliż - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

24's [24x2g sachets] -

Namibja - Ingliż - Namibia Medicines Regulatory Council

remedica (pty) ltd - ferrous fumarate; folic acid - film-coated tablet - each film-coated tablet contains ferrous ; fumarate bp 310 mg (equivalent to 100 mg ; ferrous iron) and folic acid 0,35 mg

Stati Uniti - Ingliż - NLM (National Library of Medicine)

novartis vaccines and diagnostics ltd - influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (propiolactone inactivated) (unii: k9p8pva2ug) (influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (propiolactone inactivated) - unii:k9p8pva2ug) - influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (propiolactone inactivated) 15 ug in 0.5 ml - influenza a (h1n1) 2009 monovalent vaccine is an inactivated influenza virus vaccine indicated for immunization of persons 4 years of age and older against influenza disease caused by pandemic (h1n1) 2009 virus. influenza a (h1n1) 2009 monovalent vaccine should not be administered to anyone with known systemic hypersensitivity reactions to egg proteins (eggs or egg products), or to any component of influenza a (h1n1) 2009 monovalent vaccine, or who has had a life-threatening reaction to previous influenza vaccinations [see description (11)]. novartis’ influenza a (h1n1) 2009 monovalent vaccine and seasonal trivalent influenza virus vaccine (fluvirin) are manufactured by the same process. available information for fluvirin is provided in this section. pregnancy category c: animal reproduction studies have not been conducted with influenza a (h1n1) 2009 monovalent vaccine or fluvirin. it is also not known whether influenza a (h1n1) 2009 monovalent vaccine or fluvirin can cause fetal harm when administered to

New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - aflibercept 25 mg/ml;   - concentrate for infusion - 25 mg/ml - active: aflibercept 25 mg/ml   excipient: citric acid dibasic sodium phosphate heptahydrate hydrochloric acid monobasic sodium phosphate monohydrate polysorbate 20 sodium chloride sodium citrate dihydrate sodium hydroxide sucrose water for injection - zaltrap in combination with irinotecan-fluoropyrimidine-based chemotherapy is indicated in adults with metastatic colorectal cancer previously treated with an oxaliplatin-containing regimen.